Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.

  • Read more about Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.

  • Read more about UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.

Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.

  • Read more about Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.

Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.

  • Read more about Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.

  • Read more about Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.

Systematic analysis and prediction of genes associated with monogenic disorders on human chromosome X.

  • Read more about Systematic analysis and prediction of genes associated with monogenic disorders on human chromosome X.

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.

  • Read more about Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.

Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids.

  • Read more about Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids.

Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

  • Read more about Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy.

  • Read more about Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy.

Pagination

  • Page 1
  • Next page ››
Subscribe to Nature communications

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List